Thus, we showed that AURKA level, as an independent prognostic factor, was adversely associated with clinical prognosis, suggesting that the poor chemotherapy response in gastric cancer patients might be related to high AURKA expression (Figure 1c). This evidence concerns the gene AURKA and gastric cancer.